Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age

ClinicalTrials.gov ID: NCT05871970

Public ClinicalTrials.gov record NCT05871970. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jun 25, 2026, 1:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a/b Single Arm Open Label Study to Evaluate the Safety and Efficacy of Intracystic Administration of TARA-002 in Participants Between 6 Months to Less Than 18 Years of Age for the Treatment of Macrocystic and Mixed Cystic Lymphatic Malformations

Study identification

NCT ID: NCT05871970
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Protara Therapeutics; Industry
Enrollment: 38 participants

Conditions and interventions

Conditions

Lymphatic Malformation

Interventions

TARA-002 Biological

Biological

Eligibility (public fields only)

Age range: 6 Months to 18 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 17, 2023
Primary completion: Nov 30, 2026
Completion: Apr 30, 2027
Last update posted: May 17, 2026

2023 – 2027

United States locations

U.S. sites: 10
U.S. states: 10
U.S. cities: 10

Facility	City	State	ZIP	Site status
Children's Hospital of Alabama	Birmingham	Alabama	35294	Recruiting
Arkansas Children's Hospital/UAMS	Little Rock	Arkansas	72202	Recruiting
Children's Hospital of Colorado	Aurora	Colorado	88045	Recruiting
Children's National Medical Center: Children's Research Institute	Washington D.C.	District of Columbia	20010	Recruiting
Nemours Children's Clinic - Jacksonville	Jacksonville	Florida	32207	Recruiting
Cincinnati Children's Hospital Medical Center	Cincinnati	Ohio	45229	Withdrawn
Oregon Health & Science University	Portland	Oregon	97239	Recruiting
Children's Hospital of Philadelphia: Comprehensive Vascular Anomalies Program	Philadelphia	Pennsylvania	19104	Withdrawn
Vanderbilt University Medical Center	Nashville	Tennessee	37232	Recruiting
Children's Hospital of the King's Daughters	Norfolk	Virginia	23507	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05871970, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 17, 2026 · Synced Jun 25, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05871970 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →